326 related articles for article (PubMed ID: 30846192)
1. Postoperative α-fetoprotein response predicts tumor recurrence and survival after hepatectomy for hepatocellular carcinoma: A propensity score matching analysis.
Li XL; Zhu XD; Cai H; Li Y; Zhou J; Fan J; Tang ZY; Sun HC
Surgery; 2019 Jun; 165(6):1161-1167. PubMed ID: 30846192
[TBL] [Abstract][Full Text] [Related]
2. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
3. Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.
Zhang XF; Yin ZF; Wang K; Zhang ZQ; Qian HH; Shi LH
Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):618-23. PubMed ID: 23232633
[TBL] [Abstract][Full Text] [Related]
4. Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis.
Shim JH; Yoon DL; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
Ann Surg Oncol; 2012 Nov; 19(12):3687-96. PubMed ID: 22644512
[TBL] [Abstract][Full Text] [Related]
5. Serum alpha-fetoprotein level per total tumor volume as a predictor of recurrence of hepatocellular carcinoma after resection.
Sharma Y; Weaver MJ; Ludwig DR; Fowler K; Vachharajani N; Chapman WC; Crippin JS
Surgery; 2018 May; 163(5):1002-1007. PubMed ID: 29284589
[TBL] [Abstract][Full Text] [Related]
6. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
[TBL] [Abstract][Full Text] [Related]
8. Infiltrative Hepatocellular Carcinoma: Assessment of Factors Associated With Outcomes in Patients Undergoing Hepatectomy.
Yan X; Fu X; Deng M; Chen J; He J; Shi J; Qiu Y
Medicine (Baltimore); 2016 May; 95(19):e3589. PubMed ID: 27175659
[TBL] [Abstract][Full Text] [Related]
9. Increased alpha-fetoprotein serum level is predictive for survival and recurrence of hepatocellular carcinoma in non-cirrhotic livers.
Witjes CD; Polak WG; Verhoef C; Eskens FA; Dwarkasing RS; Verheij J; de Man RA; Ijzermans JN
Dig Surg; 2012; 29(6):522-8. PubMed ID: 23548745
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma.
Hayashi M; Shimizu T; Hirokawa F; Inoue Y; Komeda K; Asakuma M; Miyamoto Y; Takeshita A; Shibayama Y; Tanigawa N
Am Surg; 2011 May; 77(5):572-8. PubMed ID: 21679590
[TBL] [Abstract][Full Text] [Related]
11. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
[TBL] [Abstract][Full Text] [Related]
12. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysis.
Jiang JH; Guo Z; Lu HF; Wang XB; Yang HJ; Yang FQ; Bao SY; Zhong JH; Li LQ; Yang RR; Xiang BD
World J Gastroenterol; 2015 Apr; 21(15):4627-34. PubMed ID: 25914472
[TBL] [Abstract][Full Text] [Related]
15. Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis.
Yang HJ; Guo Z; Yang YT; Jiang JH; Qi YP; Li JJ; Li LQ; Xiang BD
World J Gastroenterol; 2016 Jun; 22(21):5088-95. PubMed ID: 27275101
[TBL] [Abstract][Full Text] [Related]
16. Small Hepatocellular Carcinoma With Low Tumor Marker Expression Benefits More From Anatomical Resection Than Tumors With Aggressive Biology.
Jung DH; Hwang S; Lee YJ; Kim KH; Song GW; Ahn CS; Moon DB; Lee SG
Ann Surg; 2019 Mar; 269(3):511-519. PubMed ID: 28837444
[TBL] [Abstract][Full Text] [Related]
17. Proposal of an integrated staging system using albumin-bilirubin grade and serum alpha-fetoprotein values for predicting postoperative prognosis of recurrent hepatocellular carcinoma.
Matsumoto T; Shiraki T; Niki M; Sato S; Tanaka G; Shimizu T; Yamaguchi T; Park KH; Mori S; Iso Y; Ishizuka M; Kubota K; Aoki T
Eur J Surg Oncol; 2024 Jun; 50(6):108356. PubMed ID: 38685177
[TBL] [Abstract][Full Text] [Related]
18. Correlation between preoperative serum alpha-fetoprotein levels and survival with respect to the surgical treatment of hepatocellular carcinoma at a tertiary care hospital in Veracruz, Mexico.
Martínez-Mier G; Esquivel-Torres S; Nava-Lacorte A; Lajud-Barquín FA; Zilli-Hernández S; Vázquez-Ramírez LM
Rev Gastroenterol Mex; 2017; 82(4):357-360. PubMed ID: 28893428
[TBL] [Abstract][Full Text] [Related]
19. Half-life of serum alpha-fetoprotein: an early prognostic index of recurrence and survival after hepatic resection for hepatocellular carcinoma.
Shim JH; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Chung YH; Lee YS; Lee HC
Ann Surg; 2013 Apr; 257(4):708-17. PubMed ID: 23108121
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Value of Alpha-Fetoprotein Ratio in Patients With Resectable Alpha-Fetoprotein-Negative Hepatocellular Carcinoma.
Sun LY; Cen WJ; Zeng XX; Zhong YY; Deng L; Yang JJ; Li M; Wang F
Am Surg; 2024 Jun; 90(6):1240-1249. PubMed ID: 38214585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
